Latest news

IAPM Launches Oncology Pillar at ASCO: Closing the Gap Between Cancer Breakthroughs and Patient Access
CHICAGO, June 2026: The International Alliance for Personalised Medicine launched its Oncology Pillar at ASCO with a packed room and a clear message: oncology science is advancing at extraordinary speed, but too many patients still face barriers to the tests, trials, and treatments that could change their lives.

FDA Puts AI Inside the Evidence Machine

AlphaGenome Makes Variant Interpretation Political

AI Diagnosis Has Entered the Access Debate

The AMR Pipeline Is Too Thin for the Threat Ahead

TB Diagnosis Moves Closer to the Patient

Hepatitis Elimination Is Still Losing Patients Before Diagnosis

Lenacapavir Turns HIV Prevention Into an Access Stress Test

WHO’s AMR Plan Turns Access Into Preparedness

Diabetic Eye Screening Is Becoming Risk-Based
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
